7749 MEDIKIT CO.,LTD - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

7749

TSE Standard

MEDIKIT CO.,LTD

2,972

JPY

-6

(-0.20%)

Mar 13, 3:30 pm JST

18.64

USD

Mar 13, 2:30 am EDT

Result

PTS

outside of trading hours

ー

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2022	20,130	4,422	4,548	2,993	178.1	60	May 13, 2022	J-GAAP
Mar, 2023	21,607	4,118	4,177	2,864	170.7	100	May 15, 2023	J-GAAP
Mar, 2024	21,850	4,677	4,781	3,069	188.0	80	May 15, 2024	J-GAAP
Mar, 2025	22,553	4,486	4,658	3,013	204.6	90	May 15, 2025	J-GAAP
Mar, 2026 Guidance	24,000	4,500	4,592	2,924	202.0	100	May 15, 2025	J-GAAP
YoY	+6.4%	+0.3%	-1.4%	-3.0%	-1.3%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2021	May 15, 2020	20,874	4,256	4,314	2,878	50*	J-GAAP
	Nov 12, 2020	19,996	3,863	3,937	2,655	50*	J-GAAP
Results	May 14, 2021	19,312	3,778	3,871	2,659	50*	J-GAAP
Mar, 2022	May 14, 2021	Available in future release
Results	May 13, 2022
Mar, 2023	May 13, 2022
Results	May 15, 2023
Mar, 2024	May 15, 2023
Results	May 15, 2024
Mar, 2025	May 15, 2024
Results	May 15, 2025
Mar, 2026	May 15, 2025	24,000	4,500	4,592	2,924	100	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2001	9,285	+0.8	Available in future release
Mar, 2002	9,839	+6.0
Mar, 2003	10,203	+3.7
Mar, 2004	10,310	+1.0
Mar, 2005	10,339	+0.3
Mar, 2006	11,062	+7.0
Mar, 2007	11,574	+4.6
Mar, 2008	11,926	+3.0
Mar, 2009	12,331	+3.4
Mar, 2010	12,967	+5.2
Mar, 2011	13,779	+6.3
Mar, 2012	14,126	+2.5
Mar, 2013	13,990	-1.0
Mar, 2014	14,529	+3.9
Mar, 2015	14,850	+2.2
Mar, 2016	15,722	+5.9
Mar, 2017	16,850	+7.2
Mar, 2018	17,445	+3.5
Mar, 2019	18,501	+6.1
Mar, 2020	19,893	+7.5
Mar, 2021	19,312	-2.9
Mar, 2022	20,130	+4.2
Mar, 2023	21,607	+7.3
Mar, 2024	21,850	+1.1
Mar, 2025	22,553	+3.2
Mar, 2026 Guidance	24,000	+6.4	4,500	+0.3	4,592	-1.4	202.0	-1.3

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2024	21,850	4,677	21.4	6.71	5.89	0.42	188.0
Mar, 2025	22,553	4,486	19.9	6.75	5.82	0.44	204.6
Mar, 2026 Guidance	24,000	4,500	18.8	6.41	5.63	0.46	202.0

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	22,553	4,677	4,781	3,069	204.6
Fiscal Year	Mar, 2025	Mar, 2024	Mar, 2024	Mar, 2024	Mar, 2025

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2022	11,045	2,094	2,116	1,668	99.4	70	May 15, 2023	J-GAAP
Oct - Mar, 2023	11,005	2,401	2,380	1,749	107.1	45	May 15, 2024	J-GAAP
Oct - Mar, 2024	11,268	2,266	2,379	1,735	117.8	45	May 15, 2025	J-GAAP
Oct - Mar, 2025 Guidance	12,079	2,258	2,259	1,574	108.7	50	Nov 12, 2025	J-GAAP
YoY	+7.2%	-0.4%	-5.0%	-9.3%	-7.7%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2023	4,118	898	4,480	-3,582	-1,509	17,592	33.08	J-GAAP
Mar, 2024	4,677	8,064	4,834	3,230	-6,584	19,111	37.47	J-GAAP
Mar, 2025	4,486	-309	3,561	-3,870	-1,879	17,059	32.51	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2023	16,860	3,699	3,818	2,131	127.0	79.9	Feb 9, 2024	J-GAAP
Apr - Dec, 2024	17,342	3,629	3,701	2,155	146.0	79.5	Feb 10, 2025	J-GAAP
Apr - Dec, 2025	18,466	3,657	3,796	2,236	153.3	82.7	Feb 12, 2026	J-GAAP
YoY	+6.5%	+0.8%	+2.6%	+3.8%	+5.0%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jan - Mar, 2024	4,990	978	963	938	57.4	19.6	May 15, 2024	J-GAAP
Apr - Jun, 2024	5,628	1,078	1,107	405	27.4	19.2	Aug 9, 2024	J-GAAP
Jul - Sep, 2024	5,657	1,142	1,172	873	59.0	20.2	Nov 11, 2024	J-GAAP
Oct - Dec, 2024	6,057	1,409	1,422	877	59.4	23.3	Feb 10, 2025	J-GAAP
Jan - Mar, 2025	5,211	857	957	858	58.3	16.4	May 15, 2025	J-GAAP
Apr - Jun, 2025	5,890	1,022	1,068	392	26.8	17.4	Aug 8, 2025	J-GAAP
Jul - Sep, 2025	6,031	1,220	1,265	958	65.6	20.2	Nov 12, 2025	J-GAAP
Oct - Dec, 2025	6,545	1,415	1,463	886	60.7	21.6	Feb 12, 2026	J-GAAP
YoY	+8.1%	+0.4%	+2.9%	+1.0%	+2.3%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jan - Mar, 2021	4,442	+0.8	Available in future release
Apr - Jun, 2021	4,946	+3.7
Jul - Sep, 2021	5,062	+4.3
Oct - Dec, 2021	5,526	+5.3
Jan - Mar, 2022	4,596	+3.5
Apr - Jun, 2022	5,294	+7.0
Jul - Sep, 2022	5,268	+4.1
Oct - Dec, 2022	5,886	+6.5
Jan - Mar, 2023	5,159	+12.2
Apr - Jun, 2023	5,549	+4.8
Jul - Sep, 2023	5,296	+0.5
Oct - Dec, 2023	6,015	+2.2
Jan - Mar, 2024	4,990	-3.3
Apr - Jun, 2024	5,628	+1.4
Jul - Sep, 2024	5,657	+6.8
Oct - Dec, 2024	6,057	+0.7
Jan - Mar, 2025	5,211	+4.4
Apr - Jun, 2025	5,890	+4.7
Jul - Sep, 2025	6,031	+6.6
Oct - Dec, 2025	6,545	+8.1	1,415	+0.4	1,463	+2.9	60.7	+2.2

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	6,545	1,423	1,463	958	65.6
Fiscal Year	Dec, 2025	Dec, 2023	Dec, 2025	Sep, 2025	Sep, 2025

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2023	2,817.20	88.9	53,186	47,291	38,519	ー	May 15, 2023	J-GAAP
Mar, 2024	2,982.56	86.5	50,999	44,128	39,826	ー	May 15, 2024	J-GAAP
Mar, 2025	3,089.58	86.1	52,470	45,156	37,340	ー	May 15, 2025	J-GAAP
Apr - Dec, 2025	ー	87.8	51,947	45,605	38,188	0.00	Feb 12, 2026	J-GAAP

MEDIKIT CO.,LTD(7749) Financial Results